Title : Suppression Of Aberrant Activation Of NF-κB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia.

Pub. Date : 2021

PMID : 34405014






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Suppression Of Aberrant Activation Of NF-kappaB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia. parthenolide nuclear factor kappa B subunit 1 Homo sapiens
2 Also, parthenolide (PTL), which is a specific NF-kappaB inhibitor, effectively eliminated drug-resistant LSCs and enhanced the sensitivity of K562/ADM cells to doxorubicin-induced apoptosis by down-regulating NF-kappaB pathway-mediated P-gp expression. parthenolide nuclear factor kappa B subunit 1 Homo sapiens
3 Also, parthenolide (PTL), which is a specific NF-kappaB inhibitor, effectively eliminated drug-resistant LSCs and enhanced the sensitivity of K562/ADM cells to doxorubicin-induced apoptosis by down-regulating NF-kappaB pathway-mediated P-gp expression. parthenolide nuclear factor kappa B subunit 1 Homo sapiens
4 Also, parthenolide (PTL), which is a specific NF-kappaB inhibitor, effectively eliminated drug-resistant LSCs and enhanced the sensitivity of K562/ADM cells to doxorubicin-induced apoptosis by down-regulating NF-kappaB pathway-mediated P-gp expression. parthenolide nuclear factor kappa B subunit 1 Homo sapiens
5 Also, parthenolide (PTL), which is a specific NF-kappaB inhibitor, effectively eliminated drug-resistant LSCs and enhanced the sensitivity of K562/ADM cells to doxorubicin-induced apoptosis by down-regulating NF-kappaB pathway-mediated P-gp expression. parthenolide nuclear factor kappa B subunit 1 Homo sapiens